The $25 million CSL Centenary Fellowship program was established by CSL Limited in its Centenary year to support Australia’s best and brightest biomedical researchers—fostering excellence in medical research by supporting mid-career scientists to pursue world-class research at an Australian institution.
Read on for information about current Fellows.
More about the Fellowships at: www.csl.com.au/centenary/fellowships.htm
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures and markets products to treat and prevent serious human medical conditions.
CSL Media Release
CSL is proud to announce the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia.
The announcement was made last night by CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala. Mr Perreault also announced that the highly respected molecular biologist, Professor Ashley Dunn, will Chair the Selection Committee.
Journalists – get the latest science stories with our media bulletin.
Science community – be reminded about closing dates for science awards and other science news.
Find out more about our bulletins.
Follow us on social for the latest updates:
